HK1050476A1 - 含有西布曲明和脂酶抑制劑的藥物組合物 - Google Patents

含有西布曲明和脂酶抑制劑的藥物組合物

Info

Publication number
HK1050476A1
HK1050476A1 HK03101311.7A HK03101311A HK1050476A1 HK 1050476 A1 HK1050476 A1 HK 1050476A1 HK 03101311 A HK03101311 A HK 03101311A HK 1050476 A1 HK1050476 A1 HK 1050476A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
composition containing
lipase inhibitor
containing sibutramine
sibutramine
Prior art date
Application number
HK03101311.7A
Other languages
English (en)
Inventor
A‧M‧伯奇
D‧J‧希爾
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of HK1050476A1 publication Critical patent/HK1050476A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03101311.7A 1999-06-24 2003-02-20 含有西布曲明和脂酶抑制劑的藥物組合物 HK1050476A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005544 WO2001000187A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Publications (1)

Publication Number Publication Date
HK1050476A1 true HK1050476A1 (zh) 2003-06-27

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101311.7A HK1050476A1 (zh) 1999-06-24 2003-02-20 含有西布曲明和脂酶抑制劑的藥物組合物

Country Status (20)

Country Link
EP (1) EP1189638A2 (zh)
JP (1) JP2003503344A (zh)
KR (1) KR20020012293A (zh)
CN (1) CN1365287A (zh)
AU (1) AU5815100A (zh)
BG (1) BG106209A (zh)
BR (1) BR0011884A (zh)
CA (1) CA2376213A1 (zh)
CZ (1) CZ20014614A3 (zh)
GB (1) GB9914742D0 (zh)
HK (1) HK1050476A1 (zh)
HU (1) HUP0201880A3 (zh)
IL (1) IL147078A0 (zh)
MX (1) MXPA01013023A (zh)
NO (1) NO20016301L (zh)
PL (1) PL352387A1 (zh)
SK (1) SK18822001A3 (zh)
TR (1) TR200103704T2 (zh)
WO (1) WO2001000187A2 (zh)
ZA (1) ZA200110046B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
MX2009002781A (es) 2006-09-15 2009-03-30 Reviva Pharmaceuticals Inc Sintesis, metodos de uso y composiciones de cicloalquilmetilaminas .
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
US9238625B2 (en) 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Also Published As

Publication number Publication date
AU5815100A (en) 2001-01-31
HUP0201880A2 (hu) 2002-12-28
CZ20014614A3 (cs) 2004-02-18
TR200103704T2 (tr) 2002-05-21
KR20020012293A (ko) 2002-02-15
IL147078A0 (en) 2002-08-14
MXPA01013023A (es) 2003-08-01
EP1189638A2 (en) 2002-03-27
WO2001000187A3 (en) 2001-11-15
CN1365287A (zh) 2002-08-21
NO20016301D0 (no) 2001-12-21
WO2001000187A2 (en) 2001-01-04
NO20016301L (no) 2001-12-21
CA2376213A1 (en) 2001-01-04
PL352387A1 (en) 2003-08-25
JP2003503344A (ja) 2003-01-28
SK18822001A3 (sk) 2003-04-01
GB9914742D0 (en) 1999-08-25
BR0011884A (pt) 2003-08-12
BG106209A (en) 2002-09-30
HUP0201880A3 (en) 2003-03-28
ZA200110046B (en) 2003-03-06

Similar Documents

Publication Publication Date Title
EP1071403A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING STATIN AND ASPIRIN
ZA98376B (en) Sulfamide-metalloprotease inhibitors
IL131661A0 (en) Protease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
PL336589A1 (en) Serinic protease inhibitors
PL339429A1 (en) Urokinase inhibitors
ZA988469B (en) Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
IL135428A0 (en) Ace inhibitor-mmp inhibitor combinations
HUP0002247A3 (en) Protease inhibitors
PL337755A1 (en) Protease inhibitors
IL132629A0 (en) Protease inhibitors
AU9640698A (en) Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU9061798A (en) Protease variants and compositions
PL352387A1 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
EP1015438A4 (en) PROTEASE INHIBITORS
HUP0001976A3 (en) Antiviral protease inhibitors and pharmaceutical compositions
GB9815925D0 (en) HIV Intergrase inhibitors
EP0975612A4 (en) PROTEASE INHIBITORS
AU9061898A (en) Protease variants and compositions
GB9907469D0 (en) Labels and manufacture thereof
ZA200100696B (en) Pharmaceutical compositions containing lipase inhibitors
GB9713709D0 (en) Inhibitors
GB9709064D0 (en) Inhibitors
GB9703335D0 (en) Inhibitors